Grace Anne Longfellow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Grace Anne Longfellow has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Anna Rose Johnson
Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, Saint Louis, MO, United States
4 shared publications - Benjamin Ormseth
Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, United States
4 shared publications - Clara Nan-Hi Lee
Department of Surgery, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
4 shared publications - Gary B. Skolnick
Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, Saint Louis, MO, United States
4 shared publications - Mary C. Politi
Washington University
4 shared publications - Terence M. Myckatyn
Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, Saint Louis, MO, United States
4 shared publications
Latest Publications
- 1 October 2026
- Published by Wiley in The Laryngoscope
Impact of Tranexamic Acid on Head and Neck Free Flap Outcomes: A Retrospective Cohort Analysis
Objective: Tranexamic acid (TXA) is an antifibrinolytic agent studied for its role in reducing perioperative bleeding. While it has shown promise in operations requiring free tissue transfer in plastic surgery, its application in head and neck free flap reconstruction is less documented. This study evaluates the impact of TXA on head and neck free flap surgery outcomes. Methods: This was a single‐institution retrospective cohort study of adult patients who underwent head and neck reconstruction with autologous free tissue transfer between May 2023 and October 2024. Multivariable logistic regression and linear regression were used to evaluate differences between groups. Odds ratios and 95% confidence intervals were used to describe associations. Results: A total of 215 patients were included (15.3% receiving TXA). Patients who received TXA had a higher rate of intraoperative transfusions ( p = 0.049). This difference was not observed after adjustment for other factors ( p = 0.21). Patients who received TXA had a more stable hemoglobin at Postoperative Day (POD) 1 (−1.84 ± 1.62 vs. −2.77 ± 1.36 g/dL, p = 0.045), however, this difference resolved by POD 7 with no difference in postoperative transfusion rates ( p = 0.22). There was no difference in postoperative recipient site, donor site, or medical complications between groups. Conclusions: Head and neck free flap patients that received TXA had no significant difference in flap outcomes or major thrombotic events. Our results suggest that TXA is a safe option among patients undergoing free tissue transfer for head and neck reconstruction. Further prospective research with larger cohort sizes is needed to elucidate potential benefits. Level of Evidence: 3.
- 1 October 2026
- Published by Wiley in The Laryngoscope
Impact of Tranexamic Acid on Head and Neck Free Flap Outcomes: A Retrospective Cohort Analysis
Objective: Tranexamic acid (TXA) is an antifibrinolytic agent studied for its role in reducing perioperative bleeding. While it has shown promise in operations requiring free tissue transfer in plastic surgery, its application in head and neck free flap reconstruction is less documented. This study evaluates the impact of TXA on head and neck free flap surgery outcomes. Methods: This was a single‐institution retrospective cohort study of adult patients who underwent head and neck reconstruction with autologous free tissue transfer between May 2023 and October 2024. Multivariable logistic regression and linear regression were used to evaluate differences between groups. Odds ratios and 95% confidence intervals were used to describe associations. Results: A total of 215 patients were included (15.3% receiving TXA). Patients who received TXA had a higher rate of intraoperative transfusions ( p = 0.049). This difference was not observed after adjustment for other factors ( p = 0.21). Patients who received TXA had a more stable hemoglobin at Postoperative Day (POD) 1 (−1.84 ± 1.62 vs. −2.77 ± 1.36 g/dL, p = 0.045), however, this difference resolved by POD 7 with no difference in postoperative transfusion rates ( p = 0.22). There was no difference in postoperative recipient site, donor site, or medical complications between groups. Conclusions: Head and neck free flap patients that received TXA had no significant difference in flap outcomes or major thrombotic events. Our results suggest that TXA is a safe option among patients undergoing free tissue transfer for head and neck reconstruction. Further prospective research with larger cohort sizes is needed to elucidate potential benefits. Level of Evidence: 3.
- Open Access
- 3 June 2026
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
Trends in Cleft Palate Incidence in the Era of Prenatal Ultrasonography and Early Detection
Objective: To evaluate whether temporal changes in prenatal detection and North Carolina abortion rates are associated with live-birth cleft palate (CP ± L) severity phenotypes. Design: Retrospective cohort study linking patient-level clinical data to annual state abortion rates. Analyses included Pearson correlation, multivariable logistic, and interrupted time-series modeling. Setting: Single-center craniofacial program, with linkage to annual statewide abortion rates as a population-level contextual variable. Patients, Participants: 554 patients undergoing primary palatoplasty (1999 to 2021). Interventions: None. Main Outcome Measure(S): Primary outcomes: annual Veau classification distribution. Secondary outcomes: prenatal diagnosis rates and genetic syndrome or sequence rates. Results: From 2004 to 2021, the proportion of Veau I cases increased from 18.2% to 25.0% (slope β= + 0.0074 proportion-units/year; P = .051), the proportion of Veau III cases declined significantly (slope β= −0.0085 proportion-units/year; P = .011), and the proportion of Veau IV cases trended downward non-significantly. Higher abortion rates correlated with greater Veau III proportions (r = 0.63, P = .005). Logistic regression demonstrated that each 1-SD increase in abortion rate raised severe-cleft odds by 26% (odds ratio (OR) 1.26; 95% CI 1.05-1.51; P = .014), prenatal diagnosis (OR 13.13; P < .001) and presence of genetic syndrome or sequence (OR 0.36; P < .001) were also significant. Cleft severity decreased prior to 2010 (β = –0.11 units/year; P = .036) and then plateaued. Prenatal diagnosis rates increased sevenfold during the study period. Conclusions: Enhanced prenatal detection and abortion rate shifts had minimal impact on live-birth CL/P trends. The paradoxical association between higher abortion rates and severe clefts suggests that reproductive decision-making is influenced by multifactorial factors beyond detection.
- 3 June 2026
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
Open AccessTrends in Cleft Palate Incidence in the Era of Prenatal Ultrasonography and Early Detection
Objective: To evaluate whether temporal changes in prenatal detection and North Carolina abortion rates are associated with live-birth cleft palate (CP ± L) severity phenotypes. Design: Retrospective cohort study linking patient-level clinical data to annual state abortion rates. Analyses included Pearson correlation, multivariable logistic, and interrupted time-series modeling. Setting: Single-center craniofacial program, with linkage to annual statewide abortion rates as a population-level contextual variable. Patients, Participants: 554 patients undergoing primary palatoplasty (1999 to 2021). Interventions: None. Main Outcome Measure(S): Primary outcomes: annual Veau classification distribution. Secondary outcomes: prenatal diagnosis rates and genetic syndrome or sequence rates. Results: From 2004 to 2021, the proportion of Veau I cases increased from 18.2% to 25.0% (slope β= + 0.0074 proportion-units/year; P = .051), the proportion of Veau III cases declined significantly (slope β= −0.0085 proportion-units/year; P = .011), and the proportion of Veau IV cases trended downward non-significantly. Higher abortion rates correlated with greater Veau III proportions (r = 0.63, P = .005). Logistic regression demonstrated that each 1-SD increase in abortion rate raised severe-cleft odds by 26% (odds ratio (OR) 1.26; 95% CI 1.05-1.51; P = .014), prenatal diagnosis (OR 13.13; P < .001) and presence of genetic syndrome or sequence (OR 0.36; P < .001) were also significant. Cleft severity decreased prior to 2010 (β = –0.11 units/year; P = .036) and then plateaued. Prenatal diagnosis rates increased sevenfold during the study period. Conclusions: Enhanced prenatal detection and abortion rate shifts had minimal impact on live-birth CL/P trends. The paradoxical association between higher abortion rates and severe clefts suggests that reproductive decision-making is influenced by multifactorial factors beyond detection.
- Open Access
- 13 February 2026
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 12, e87683
Correction: Social Media as a Platform for Cancer Care Decision-Making Among Women: Internet Survey-Based Study on Trust, Engagement, and Preferences
[This corrects the article DOI: 10.2196/64724.].
- 13 February 2026
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 12, e87683
Open AccessCorrection: Social Media as a Platform for Cancer Care Decision-Making Among Women: Internet Survey-Based Study on Trust, Engagement, and Preferences
[This corrects the article DOI: 10.2196/64724.].
- 7 November 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (3) , 895-904.e12
Racial and/or ethnic and rural disparities in health care utilization before major lower extremity amputation in patients with peripheral artery disease
- 7 November 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (3) , 895-904.e12
Racial and/or ethnic and rural disparities in health care utilization before major lower extremity amputation in patients with peripheral artery disease
- 14 October 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 174 (1) , 152-162
Post‐Radiation Microbiological Changes in Osteoradionecrosis: Investigating the Microbial Landscape
Objective: To evaluate the microbiologic characteristics, antibiotic resistance patterns, and clinical predictors of reconstruction in patients with osteoradionecrosis of the jaw (ORNJ). Study Design: Retrospective cohort study. Setting: Single tertiary care academic medical center. Methods: Eighty‐four adult patients treated for ORNJ between January 2023 and August 2024 were included. Clinical and microbiologic data were extracted from the electronic health record. Culture results, antibiotic resistance profiles, and reconstructive outcomes were analyzed. Logistic regression was used to identify predictors of autologous reconstruction, Gram‐negative infection, and Actinomyces isolation. Results: Among 84 patients (median age 63.3), 73.8% had cultures obtained, and 92.9% received antibiotics. Bacterial species were isolated in 58.2% of 134 cultures, with Actinomyces (23.9%) and Streptococcus anginosus (7.5%) most frequent. Gram‐negative organisms were identified in 22.6% and independently predicted autologous reconstruction (odds ratio [OR] = 14.81; 95% confidence interval [CI]: 2.59‐84.67; P = .0025). Fistula presence was significantly associated with Gram‐negative infection (OR = 6.57; 95% CI: 1.76‐24.47; P = .005). High resistance was observed to ampicillin (47.1%) and cefazolin (35.3%), while gentamicin showed the highest susceptibility (75.9%). Posterior mandibular involvement and pathologic fracture were associated with reduced odds of reconstruction. Conclusions: ORNJ exhibits a polymicrobial and antibiotic‐resistant profile. Gram‐negative infection is a key predictor of the need for autologous reconstruction and may reflect more severe disease. These findings support the use of culture‐directed therapy and highlight the importance of integrating microbiologic and anatomic factors in ORNJ management. Level of Evidence: IV.
- 14 October 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 174 (1) , 152-162
Post‐Radiation Microbiological Changes in Osteoradionecrosis: Investigating the Microbial Landscape
Objective: To evaluate the microbiologic characteristics, antibiotic resistance patterns, and clinical predictors of reconstruction in patients with osteoradionecrosis of the jaw (ORNJ). Study Design: Retrospective cohort study. Setting: Single tertiary care academic medical center. Methods: Eighty‐four adult patients treated for ORNJ between January 2023 and August 2024 were included. Clinical and microbiologic data were extracted from the electronic health record. Culture results, antibiotic resistance profiles, and reconstructive outcomes were analyzed. Logistic regression was used to identify predictors of autologous reconstruction, Gram‐negative infection, and Actinomyces isolation. Results: Among 84 patients (median age 63.3), 73.8% had cultures obtained, and 92.9% received antibiotics. Bacterial species were isolated in 58.2% of 134 cultures, with Actinomyces (23.9%) and Streptococcus anginosus (7.5%) most frequent. Gram‐negative organisms were identified in 22.6% and independently predicted autologous reconstruction (odds ratio [OR] = 14.81; 95% confidence interval [CI]: 2.59‐84.67; P = .0025). Fistula presence was significantly associated with Gram‐negative infection (OR = 6.57; 95% CI: 1.76‐24.47; P = .005). High resistance was observed to ampicillin (47.1%) and cefazolin (35.3%), while gentamicin showed the highest susceptibility (75.9%). Posterior mandibular involvement and pathologic fracture were associated with reduced odds of reconstruction. Conclusions: ORNJ exhibits a polymicrobial and antibiotic‐resistant profile. Gram‐negative infection is a key predictor of the need for autologous reconstruction and may reflect more severe disease. These findings support the use of culture‐directed therapy and highlight the importance of integrating microbiologic and anatomic factors in ORNJ management. Level of Evidence: IV.
- Open Access
- 28 September 2025
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 18
Fusarium Species Fungal Prosthetic Joint Infection of the Proximal Interphalangeal Joint After Silicone Arthroplasty: A Case Report
Background: Prosthetic joint infection (PJI) following proximal interphalangeal joint (PIPJ) arthroplasty is rare, with most reported cases involving bacterial organisms. Fungal PJIs comprise Fusarium species an exceptionally uncommon cause, particularly in the upper extremity. Case Presentation: A 60-year-old female with a history of rheumatoid arthritis on methotrexate and adalimumab underwent right long finger PIPJ silicone arthroplasty. She presented 12 weeks postoperatively with pain, swelling, and radiographic changes concerning for PJI despite normal inflammatory markers. Implant explantation with debridement was performed, and intraoperative cultures grew Fusarium species. Initial oral voriconazole was insufficient, necessitating readmission for intravenous liposomal amphotericin B and oral posaconazole. Thirty-nine days after completing her 6-month antifungal course, she underwent arthrodesis, which later failed, requiring revision with iliac crest autograft and dorsal plate fixation. At latest follow-up, she remained pain-free with radiographic union and no recurrent infection. Conclusions: Based on available literature, this represents the first reported case of Fusarium PJI following silicone arthroplasty of the hand. This underscores the importance of maintaining suspicion for atypical pathogens in immunosuppressed hosts and highlights the complexities managing fungal infections in small joint arthroplasty.
- 28 September 2025
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 18
Open AccessFusarium Species Fungal Prosthetic Joint Infection of the Proximal Interphalangeal Joint After Silicone Arthroplasty: A Case Report
Background: Prosthetic joint infection (PJI) following proximal interphalangeal joint (PIPJ) arthroplasty is rare, with most reported cases involving bacterial organisms. Fungal PJIs comprise Fusarium species an exceptionally uncommon cause, particularly in the upper extremity. Case Presentation: A 60-year-old female with a history of rheumatoid arthritis on methotrexate and adalimumab underwent right long finger PIPJ silicone arthroplasty. She presented 12 weeks postoperatively with pain, swelling, and radiographic changes concerning for PJI despite normal inflammatory markers. Implant explantation with debridement was performed, and intraoperative cultures grew Fusarium species. Initial oral voriconazole was insufficient, necessitating readmission for intravenous liposomal amphotericin B and oral posaconazole. Thirty-nine days after completing her 6-month antifungal course, she underwent arthrodesis, which later failed, requiring revision with iliac crest autograft and dorsal plate fixation. At latest follow-up, she remained pain-free with radiographic union and no recurrent infection. Conclusions: Based on available literature, this represents the first reported case of Fusarium PJI following silicone arthroplasty of the hand. This underscores the importance of maintaining suspicion for atypical pathogens in immunosuppressed hosts and highlights the complexities managing fungal infections in small joint arthroplasty.
- Open Access
- 19 September 2025
- Published by SAGE Publications in The American Surgeon™
- Vol. 92 (3) , 762-768
Who’s Deciding? A Study of Patient-Surgeon Discussions About Contralateral Prophylactic Mastectomy
Background: Despite rising rates of contralateral prophylactic mastectomy (CPM), little is known about how surgeons and patients communicate about the procedure. This study is among the first to use real-time audio recordings of CPM discussions, link conversations to treatment choice, and include multiple institutions. We assessed surgeon-patient discussions, focusing on how often CPM was addressed, who initiated it, and how decisions were made. Methods: We recruited surgeons and patients from three academic centers and audio-recorded the first surgical consultation for patients with (1) early-stage unilateral breast cancer or ductal carcinoma in situ and (2) no strong family history or BRCA mutation. Transcripts were analyzed using an inductive, qualitative approach to generate themes and detect patterns. Results: Twenty-seven patients and eight surgeons participated. In 14 cases, neither patient nor surgeon mentioned CPM. In the remaining 13, surgeons initiated the topic in 10, typically while introducing surgical options. Of the four patients who received CPM, each had a strong initial preference for CPM and was undeterred by the surgeon’s cautionary statements against it. When patients lacked strong preferences for CPM, they generally followed surgeon recommendations to forego CPM or to delay the decision until tests (eg, genetics and MRI) were complete. Discussion: Surgeons, not patients, most commonly initiated CPM discussions. Initial patient preference strongly influenced surgical decisions. Surgeon recommendations to wait for additional information shaped decision making only when patients were initially undecided. Future research should explore how patients form preferences prior to consultation and how best to address them during clinical conversations.
- 19 September 2025
- Published by SAGE Publications in The American Surgeon™
- Vol. 92 (3) , 762-768
Open AccessWho’s Deciding? A Study of Patient-Surgeon Discussions About Contralateral Prophylactic Mastectomy
Background: Despite rising rates of contralateral prophylactic mastectomy (CPM), little is known about how surgeons and patients communicate about the procedure. This study is among the first to use real-time audio recordings of CPM discussions, link conversations to treatment choice, and include multiple institutions. We assessed surgeon-patient discussions, focusing on how often CPM was addressed, who initiated it, and how decisions were made. Methods: We recruited surgeons and patients from three academic centers and audio-recorded the first surgical consultation for patients with (1) early-stage unilateral breast cancer or ductal carcinoma in situ and (2) no strong family history or BRCA mutation. Transcripts were analyzed using an inductive, qualitative approach to generate themes and detect patterns. Results: Twenty-seven patients and eight surgeons participated. In 14 cases, neither patient nor surgeon mentioned CPM. In the remaining 13, surgeons initiated the topic in 10, typically while introducing surgical options. Of the four patients who received CPM, each had a strong initial preference for CPM and was undeterred by the surgeon’s cautionary statements against it. When patients lacked strong preferences for CPM, they generally followed surgeon recommendations to forego CPM or to delay the decision until tests (eg, genetics and MRI) were complete. Discussion: Surgeons, not patients, most commonly initiated CPM discussions. Initial patient preference strongly influenced surgical decisions. Surgeon recommendations to wait for additional information shaped decision making only when patients were initially undecided. Future research should explore how patients form preferences prior to consultation and how best to address them during clinical conversations.
- Open Access
- 8 September 2025
- Published by SAGE Publications in Plastic Surgery
Thoracic Outlet Syndrome After Implant-based Breast Reconstruction
Background: Thoracic outlet syndrome (TOS) is characterized by compression of neurovascular structures within the thoracic outlet. Symptoms include upper-extremity paresthesias, weakness, and, in some-cases, effort-induced thrombosis. Implant-based breast reconstruction has been identified as a potential etiology of TOS given the anatomic relationship of the pectoralis muscles to the thoracic outlet. This study aims to investigate the relationship between implant-based reconstruction and TOS diagnosis. Methods: A retrospective, single-institution review was conducted to identify female subjects that presented for evaluation of TOS-like symptoms between April 2014 and December 2022. Results: 319 female patients presented to our institution for evaluation. Sixteen (5.0%) of these subjects previously underwent implant-based breast reconstruction, for which the following outcomes were considered: symptom type, timing to onset of symptoms relative to timing of reconstruction, and diagnosis of TOS as confirmed by imaging or testing. Seven of 16 patients (43.8%) received a formal diagnosis of TOS from a surgical specialist and were also found to have subpectoral implants. Conclusions: Based on clinical evidence, breast reconstruction has been acknowledged as a probable etiology for TOS. However, over half of symptomatic subjects did not receive a formal diagnosis of TOS, suggesting a potential for improvement in screening methods for this population. While the data of this study suggests that the plane of reconstruction, specifically subpectoral, could have an association with TOS, further research with a larger patient cohort is necessary to establish a definitive causal relationship.
- 8 September 2025
- Published by SAGE Publications in Plastic Surgery
Open AccessThoracic Outlet Syndrome After Implant-based Breast Reconstruction
Background: Thoracic outlet syndrome (TOS) is characterized by compression of neurovascular structures within the thoracic outlet. Symptoms include upper-extremity paresthesias, weakness, and, in some-cases, effort-induced thrombosis. Implant-based breast reconstruction has been identified as a potential etiology of TOS given the anatomic relationship of the pectoralis muscles to the thoracic outlet. This study aims to investigate the relationship between implant-based reconstruction and TOS diagnosis. Methods: A retrospective, single-institution review was conducted to identify female subjects that presented for evaluation of TOS-like symptoms between April 2014 and December 2022. Results: 319 female patients presented to our institution for evaluation. Sixteen (5.0%) of these subjects previously underwent implant-based breast reconstruction, for which the following outcomes were considered: symptom type, timing to onset of symptoms relative to timing of reconstruction, and diagnosis of TOS as confirmed by imaging or testing. Seven of 16 patients (43.8%) received a formal diagnosis of TOS from a surgical specialist and were also found to have subpectoral implants. Conclusions: Based on clinical evidence, breast reconstruction has been acknowledged as a probable etiology for TOS. However, over half of symptomatic subjects did not receive a formal diagnosis of TOS, suggesting a potential for improvement in screening methods for this population. While the data of this study suggests that the plane of reconstruction, specifically subpectoral, could have an association with TOS, further research with a larger patient cohort is necessary to establish a definitive causal relationship.
- Open Access
- 1 September 2025
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 12
Diversity in Gender, Race, and Specialty Among US Allopathic Medical School Leadership
Purpose: The demographic composition of United States (US) medical school leadership remains underexplored, despite growing recognition of workforce disparities in gender, race, and specialty. These gaps may affect patient care, mentorship, and education. This study examines demographic patterns in US allopathic medical school leaders relative to the broader physician and general US populations. Methods: From June 2023 to January 2024, we reviewed 154 US allopathic (MD) medical schools. We analyzed individual leadership structures and patterns in each institution. Institutional websites and publicly available sources were used to collect data on leadership demographics (gender, race, age), academic background (degrees, specialty), prior leadership roles, and research productivity via PubMed searches. Results: In total, 154 allopathic medical schools in 46 states met inclusion criteria. We identified 1097 individuals (56.97% male, 70.46% White/Asian) serving as Dean, Senior Associate Dean, Assistant Dean, or equivalent. Most leaders held an MD or equivalent (76.12%), while 23.79% held solely a PhD. The majority practiced nonprocedural specialties (61.71%) and had prior leadership roles, such as Department Chair/Vice Chair (34.28%) or Program Director/Associate Director for Residency or Fellowship (18.24%). Most held or had held professorships (68.55%). Conclusions: Most allopathic medical school leaders come from nonprocedural specialties, which may influence students’ mentorship access and specialty choices. With gender, race, and specialty disparities existing among medical leadership, diversification of these leaders could enhance the medical school learning environment, broaden mentorship, and help align the physician workforce with the population it serves.
- 1 September 2025
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 12
Open AccessDiversity in Gender, Race, and Specialty Among US Allopathic Medical School Leadership
Purpose: The demographic composition of United States (US) medical school leadership remains underexplored, despite growing recognition of workforce disparities in gender, race, and specialty. These gaps may affect patient care, mentorship, and education. This study examines demographic patterns in US allopathic medical school leaders relative to the broader physician and general US populations. Methods: From June 2023 to January 2024, we reviewed 154 US allopathic (MD) medical schools. We analyzed individual leadership structures and patterns in each institution. Institutional websites and publicly available sources were used to collect data on leadership demographics (gender, race, age), academic background (degrees, specialty), prior leadership roles, and research productivity via PubMed searches. Results: In total, 154 allopathic medical schools in 46 states met inclusion criteria. We identified 1097 individuals (56.97% male, 70.46% White/Asian) serving as Dean, Senior Associate Dean, Assistant Dean, or equivalent. Most leaders held an MD or equivalent (76.12%), while 23.79% held solely a PhD. The majority practiced nonprocedural specialties (61.71%) and had prior leadership roles, such as Department Chair/Vice Chair (34.28%) or Program Director/Associate Director for Residency or Fellowship (18.24%). Most held or had held professorships (68.55%). Conclusions: Most allopathic medical school leaders come from nonprocedural specialties, which may influence students’ mentorship access and specialty choices. With gender, race, and specialty disparities existing among medical leadership, diversification of these leaders could enhance the medical school learning environment, broaden mentorship, and help align the physician workforce with the population it serves.